Becton Dickinson CFO Chris DelOrefice to Step Down; Vitor Roque Appointed Interim Successor
American medical technology giant Becton Dickinson and Co. (BD) has announced that Chris DelOrefice, Executive Vice President and Chief Financial Officer, will depart the company on December 5, 2025, to pursue a new professional opportunity.
Becton Dickinson And Company (BD) | 16/10/2025 | By Dineshwori
BD Spins Off Biosciences and Diagnostics Business in USD 17.5B Merger with Waters
Becton, Dickinson and Company (BD) and Waters Corporation have entered into a definitive agreement to merge BD’s Biosciences and Diagnostic Solutions business with Waters in a deal valued at approximately USD 17.5 billion.
Becton, Dickinson And Company (BD) | 18/07/2025 | By Dineshwori | 285
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy